Triglav Skladi, D.O.O. Vertex Pharmaceuticals Inc Transaction History
Triglav Skladi, D.O.O.
- $1.36 Billion
- Q2 2025
A detailed history of Triglav Skladi, D.O.O. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Triglav Skladi, D.O.O. holds 3,450 shares of VRTX stock, worth $1.41 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,450
Previous 3,450
-0.0%
Holding current value
$1.41 Million
Previous $1.67 Billion
99.91%
% of portfolio
0.11%
Previous 0.14%
Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,809Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.7 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.71 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.59 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.81 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...